CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-05-06 | Cubitt Andrew See Remarks | Grant or award · Stock Option (right to buy) | +5,657 | 5,657 | ||
| 2015-05-06 | Graham Marcy See Remarks | Grant or award · Stock Option (right to buy) | +10,686 | 10,686 | ||
| 2015-05-06 | MENDLEIN JOHN CEO & Executive Chariman | Grant or award · Stock Option (right to buy) | +163,437 | 163,437 |
Page 25 of 25 · 483 trades